Medeon Biodesign Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	7,684	3,654	4,294	5,092	6,592	3,642
Market Cap Growth	103.39%	-14.91%	-15.67%	-22.76%	80.99%	-13.33%
Enterprise Value	6,949	2,482	2,208	3,643	4,155	2,451
Last Close Price	83.30	39.26	46.19	54.26	69.38	38.45
PE Ratio	-	-	-	-	3.17	-
PS Ratio	20.12	12.48	21.88	17.07	95.60	29.60
PB Ratio	6.14	2.38	1.81	1.39	1.57	1.38
P/TBV Ratio	7.54	2.69	2.00	1.49	1.63	1.99
EV/Sales Ratio	18.20	8.48	11.25	12.21	60.25	19.92
EV/FCF Ratio	-10.27	-	-	-	-	-
Debt / Equity Ratio	0.10	0.11	0.08	0.05	0.01	0.19
Net Debt / Equity Ratio	-0.65	-0.68	-0.82	-0.37	-0.55	-0.64
Net Debt / EBITDA Ratio	1.10	1.24	2.45	2.93	5.01	5.95
Net Debt / FCF Ratio	1.20	1.15	2.41	2.24	7.69	9.88
Asset Turnover	0.21	0.13	0.06	0.07	0.02	0.04
Inventory Turnover	12.21	9.33	17.47	-	-	1.94
Quick Ratio	5.68	5.81	9.89	8.09	14.76	11.93
Current Ratio	5.98	6.11	10.05	8.25	14.91	12.25
Return on Equity (ROE)	-52.65%	-44.56%	-42.09%	-12.66%	-17.16%	-14.19%
Return on Assets (ROA)	-27.54%	-23.94%	-15.46%	-7.26%	-8.07%	-7.33%
Return on Capital Employed (ROCE)	-59.00%	-53.30%	-33.20%	-12.70%	-11.80%	-11.00%
Earnings Yield	-9.63%	-22.05%	-28.06%	-8.52%	31.53%	-5.29%
FCF Yield	-8.81%	-24.82%	-18.87%	-11.82%	-4.58%	-4.71%
Dividend Yield	-	-	-	0.88%	1.14%	-
Buyback Yield / Dilution	-0.07%	-0.11%	-0.02%	0.07%	-0.48%	-0.05%
Total Shareholder Return	-0.07%	-0.11%	-0.02%	0.95%	0.66%	-0.05%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.